ARTICLE
21 September 2023

Holland & Knight Health Dose: September 19, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • This Week: Pivotal Week on Spending
  • Sanders, Marshall Release Health Care Workforce Package
  • House Floor Schedule on Health Bills Fluctuating
  • Sanders Agrees to Confirmation Hearing for NIH Nominee
  • House Committee on Energy and Commerce Holds Drug Shortage Hearing
  • Ways and Means Committee "Member Day" Meeting
  • Senators Express Concern Over DEA's Proposed Telemedicine Rule
  • White House Cancer Moonshot Advances $240 Million Investment
  • DEA Telemedicine Listening Session

Read the full Health Dose »

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More